PTX 0.00% 3.9¢ prescient therapeutics limited

PTX Media related, page-1173

  1. 294 Posts.
    lightbulb Created with Sketch. 249
    From an article I just read it is more about diversification with a new treatment line.There only seems to be one other candidate as a similar stage asset which is being developed by Teva Pharmaceutical which is a jointly owned company by Pfizer and Roivant Sciences. From the article it appears that it is also a bit about keeping up with the Joneses….I guess it goes to show that when the stars align they align, which is a good thing given where most asx biotech SP are at the moment.
    https://www.investors.com/news/technology/rxdx-stock-merck-nabs-deal-as-keytruda-patent-expiration-looms/

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.